Medgend Icon

Ledgend of Medicine







discontinued


Patanase FDA Approved Drugs

OLOPATADINE HYDROCHLORIDE [Olopatadine HydrochlorideC21H23NO3ClH]
RX
-
0.665mg/spray (nasal spray, metered)
eq 0.1% base (ophthalmic solution/drops)
eq 0.2% base (ophthalmic solution/drops)
Apotex IncOct 8, 2014
Perrigo IsraelJan 31, 2017
Akorn IncJan 10, 2017
Aurobindo Pharma LtdDec 18, 2015
Somerset Theraps LlcDec 7, 2015
Usv North AmericaDec 7, 2015
Wockhardt LtdJun 28, 2017
Zach System SpaDec 7, 2015
Barr Labs IncJul 13, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PATADAY [Olopatadine HydrochlorideC21H23NO3ClH]
RX
-
eq 0.2% base (ophthalmic solution/drops)
Novartis Pharms CorpDec 22, 2004
  • Method of treating allergic conjunctivitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PATANASE [Olopatadine HydrochlorideC21H23NO3ClH]
RX
-
0.665mg/spray (nasal spray, metered)
Novartis Pharms CorpApr 15, 2008
  • Allergic rhinitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PATANOL [Olopatadine HydrochlorideC21H23NO3ClH]
RX
-
eq 0.1% base (ophthalmic solution/drops)
Novartis Pharms CorpDec 18, 1996
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PAZEO [Olopatadine HydrochlorideC21H23NO3ClH]
RX
-
eq 0.7% base (ophthalmic solution/drops)
Novartis Pharms CorpJan 30, 2015
  • Treatment of ocular itching associated with allergic conjunctivitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.